-
-
-
-
-
-
-
EyePoint Inc. (EYPT) PT Raised to $29 at Chardan
-
-
-
-
-
-
-
EyePoint Pharmaceuticals (EYPT) Misses Q2 EPS by 4c
-
-
-
-
-
-
-
EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 14c
-
-
-
-
-
-
-
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
-
-
-
-
-
-
EyePoint Pharmaceuticals (EYPT) Tops Q3 EPS by 17c
-
-
-
-
-
-
-
EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 55c
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Clariant, Polished, Singularity, and EyePoint and Encourages Investors to Contact the Firm
-
1,223,277 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

